ABSTRACT It remains unclear how a limited amount of maternal transcription factor Dorsal (Dl) directs broad expression of short gastrulation (sog) throughout the presumptive neurogenic ectoderm in the Drosophila early embryo. Here, we present evidence that the sog shadow enhancer employs dual modes of transcriptional synergy to produce this broad pattern. Bioinformatics analyses indicated that a minimal enhancer region, systematically mapped in vivo, contains five Dl-, three Zelda (Zld)-, and three Bicoid (Bcd)-binding sites; four of these five Dl-binding sites are closed linked to two Zld-and two Bcd-binding sites. Mutations of either the linked Zld-or Bcd-binding sites led to severe reduction in lacZ expression width, length, and/or strength in transgenic embryos. In addition, alteration of the helical phasing in this enhancer region by insertion of spacer sequences between linked sites also resulted in aberrant lacZ expression. These results suggest that synergistic interactions between Dl and Zld and between DI and Bcd are required for broad sog expression.
Introduction
The dorsal-ventral (DV) patterning of the Drosophila early embryo is regulated by the maternal transcription factor dl, which is related to mammalian NFκB (Rushlow et al., 1989) . The sequence-specific activator Dl forms a broad nuclear gradient, with peak levels in ventral regions and progressively diminishing levels in lateral and dorsal regions of the embryo (Anderson et al., 1985) . Basically, the Dl gradient produces three discrete patterns of gene expression along the DV axis of cellularizing embryos (Hong et al., 2008b) . The highest levels of the Dl gradient activate many of the Dl target genes such as twist (twi) and snail (sna) in the ventral one-third of the embryo that differentiates into the presumptive mesoderm (Jiang et al., 1991; Ip et al., 1992) . Intermediate levels of gradient direct expression of target genes including brinker (brk) in the ventral part of the presumptive neurogenic ectoderm (Markstein et al., 2002) . The lowest levels of the gradient activate genes such as sog throughout the neurogenic ectoderm (Markstein et al., 2002) . Intriguingly, the same levels of the Dl protein function as a repressor to restrict expression of decapentaplegic (dpp), zerknüllt (zen), and tolloid (tld) in the dorsal ectoderm (Jiang et al., 1992) . Altogether, the Dl gradient activates 60-70 target genes to initiate DV patterning in a concentration-dependent manner (Hong et al., 2008b) .
Dl protein does not work alone to establish differential expression patterns across the DV axis of early embryos. For instance, the highest levels of the Dl gradient in the mesoderm activate a basic helix-loop-helix (bHLH) transcription activator twi (Jiang et al., 1991) , whose product also forms a nuclear gradient that is steeper than the Dl gradient. Dl and Twi cooperatively direct expression of a zinc-finger repressor Sna that establishes the dorsal limit of the presumptive mesoderm (Ip et al., 1992) . Another type of transcriptional synergy is observed in neurogenic gene expression. Enhancers directing gene expression in the ventral regions of the neurogenic ectoderm contain a fixed arrangement of the closely linked Dl-and Twi-binding sites. Intermediate and low levels of Dl and Twi, respectively, cooperatively occupy the linked sites to delimit threshold responses of the enhancers to the Dl gradient and synergistically activate neurogenic genes such as rhomboid (rho) 74 D.-H. Shin and J.-W. Hong and ventral nervous system defective (vnd) (Zinzen et al., 2006) . These findings raise the possibility that synergistic interactions with Twi may also allow the lowest levels of Dl to direct broad sog expression throughout the neurogenic ectoderm. However, a couple of studies presented evidence that the possibility may not be the case (Szymanski and Levine, 1995; Liberman and Stathopoulos, 2009) , suggesting that Dl may interact synergistically with other cooperative partners besides Twi to generate broad sog expression throughout the neurogenic ectoderm. However, the details of the mechanism are unclear.
The broad pattern of endogenous sog expression in the presumptive neurogenic ectoderm is controlled by two separate enhancers, called the primary enhancer and shadow enhancer (Hong et al., 2008a) . About 400-bp primary enhancer has been identified by computational analyses of the genome-wide distribution of the Dl recognition sequence (Markstein et al., 2002) . Subsequent chromatin immunoprecipitation (ChIP)-chip assays have showed that the sog locus contains a secondary enhancer to direct sog expression in the neurogenic ectoderm (Hong et al., 2008a) . The two redundant enhancers are referred to as the "primary" and "shadow" enhancer, respectively, based on the chronological order of their identification rather than any functional differences. Here, evidence is presented that the sog shadow enhancer employs transcriptional synergies between Dl and Zld and between Dl and Bcd to produce the broad stripes of sog expression. The sog minimal enhancer, systematically determined in transgenic embryos, contains five Dl-binding sites, four of which are closely linked to two Zld-and two Bcd-binding sites. Mutation of both the linked Zld-and Bcd-binding sites and extension of the distance between the Dl-and linked sites led to a dramatic reduction in lacZ expression in transgenic embryos. It is conceivable that the broad sog expression observed in the neurogenic ectoderm is at least in part due to synergistic interactions between Dl and either Zld or Bcd.
Results
A 0.582 kb region within the shadow enhancer is sufficient to direct sog expression in the presumptive neurogenic ectoderm
To investigate how the sog shadow enhancer directs the broad pattern, the minimal region possessing enhancer activity was determined by 5' and 3' truncation analysis in transgenic embryos (Fig. 1 ). First, a 5' deletion set including four constructs (0.732, 0.616, 0.404, and 0.213 kb) was generated. The 0.732 kb construct directed broad and strong lacZ expression comparable to that mediated by the full-length (0.884 kb) construct. However, further truncation of the 0.732 kb construct (0.616 and 0.404 kb) led to severe reduction in lacZ expression, and the 0.213 kb construct did not activate the lacZ reporter. These results suggest that the 5' end of the minimal region is located somewhere between the 5' ends of the 0.732-and 0.616 kb constructs. A series of 3' deletion constructs (0.731, 0.542,s and 0.351) were also created to map the 3' end of the minimal region. The 0.731 kb construct directed broad lacZ expression in the presumptive ectoderm. Two more deletion constructs (0.542 and 0.351 kb), however, showed severely impaired lacZ expression. These results suggest that the 3' end of the minimal region is located somewhere between the 3' ends of the 0.731-and 0.542 kb constructs. Five more constructs (0.686, 0.610, 0.502, 0.582, and 0.450) were produced to further refine the minimal region. The 0.686 kb construct directed lacZ expression similar to that mediated by the full-length, 0.732-, or 0.731 kb constructs.
Intriguingly, 3' ~70-bp deletion (0.610 kb) of the 0.686 kb construct resulted in a catastrophic reduction in lacZ expression, suggesting that this short region contains an essential element(s) required for sog enhancer activity. Consistently, the 0.502 kb construct derived from further 5' deletion of the 0.610 kb construct almost failed to activate the reporter gene. However, 3' ~70-bp extension of the 0.502 kb construct allowed restoration of the enhancer activity of the 0.582 kb construct. Although the 0.450 kb construct could still activate lacZ, lacZ expression was weaker in the anterior half of the embryo. Together, these results suggest that the 0.582 kb region within the sog shadow enhancer is necessary and sufficient to direct lacZ expression in a pattern almost congruent with the endogenous sog expression pattern. Fig. S1 and S2) for Dl-, Zld-, Sna-, and Bcd-binding sites (Fig. 2) . The ClusterDraw program is an r-scan-based algorithm that has been used to identify the binding motifs and binding clusters of specific combinations of transcription factors (Papatsenko, 2007) . To increase the statistical power of the in silico analysis, an identical ClusterDraw analysis was repeated twice with two different sets of PFMs for the four transcription factors. One set of PFMs was generated by motif alignments obtained from the in vitro binding data (Papatsenko, 2007) (Fig. 2A) and the other from the in vivo binding data (Zhu et al., 2011) (Fig. 2B) . Binding sites for the zincfinger repressor Sna were included in these analyses because Sna restricts sog expression to the neurogenic ectoderm by repressing sog expression in the presumptive mesoderm (Cowden and Levine, 2002) , suggesting that the minimal enhancer includes at least one high-quality Sna-binding site.
ClusterDraw analyses over a ~62 kb genomic region encompassing the sog locus identified two clusters repeatedly ( Fig. 2A  and B) . Although the patterns of the best cluster p-values along the axis of match probability cutoff (-logP) were slightly different in the two independent analyses, the two best clusters in each analysis coincided with the primary and shadow enhancers ( Fig.  2A and B, dotted boxes, Table S8 ). These results suggest that the primary and shadow enhancers of sog contain the most significant clusters of Dl-, Zld-, Sna-, and Bcd-binding motifs across the ~62 kb genomic region. The ClusterDraw algorithm also provides information about the location and quality [cumulative match probability (-logP)] of each binding site found in the clusters that ClusterDraw has identified (Table S2-S5) . Binding sites commonly identified by the two repeated analyses and whose cumulative match probability values were higher than the match probability cutoff value were defined as functional binding motifs (Fig. 2C and Tables S2-S5 , see Supplementary Material for more details). The cluster corresponding to the shadow enhancer contained four Dl-, three Zld-, four Sna-, and four Bcd-binding sites. Intriguingly, two Dl-binding sites (D3 and D5) were closely linked with the two Zld-binding sites (Z1 and Z3) and another two Dl-binding sites (D1 and D2) were located nearby the two Bcd-binding sites (B2 and B3). In addition, all binding sites were included in the minimal region of the sog shadow enhancer except the first Bcd-binding site (B1) (Fig. 2D) . These results suggest that there may be synergistic interactions between Dl and Zld and between and Dl and Bcd.
Close linkages between Dl-and Zld-binding sites in the minimal enhancer are required for the broad lacZ expression Next, we tested if the Zld-binding sites are indispensable for minimal enhancer activity (Fig. 3) . The 0.582 kb construct directed broad and strong lacZ expression that recapitulated endogenous sog expression in the neurogenic ectoderm (Fig. 3A , compare with Fig. 1, top panel) . However, mutations of all the Zld-binding sites resulted in dramatic reduction in lacZ expression width (Fig.  3B ). In addition, mutations in the two Zld-binding sites (Z1 and Z3) located adjacent to Dl-binding sites (D3 and D5) created a narrow pattern of lacZ expression similar to that mediated by the 0.582ΔZld123 construct (Fig. 3C) . Moreover, removal of only either the first (Z1) (Fig. 3D ) or third (Z3) (Fig. 3F ) Zld-binding site in the minimal enhancer led to even narrower lacZ expression along the DV axis than that directed by the 0.582ΔZld123 construct. Mutation of the second Zld-binding sites (Z2) alone, however, directed lacZ expression much broader than any lacZ patterns mediated by the mutant enhancers of the Zld-binding sites (Fig. 3E) . These results suggest that the first and third Zld-binding sites (Z1 and Z3) are required for broad sog expression, whereas loss of the second Zld-binding site (Z2) is tolerable.
The fact that the Zld-binding sites required for the broad pattern were closely linked to Dl-binding sites prompted us to reason (Table S1 ) led to severe reduction in lacZ expression width along the DV axis, comparable to that directed by the enhancer containing either first or third mutant Zld-binding sites (Fig. 3G , compare with D and F). The addition of a 7-bp sequence between the D5 and Z3 sites resulted in lacZ expression similar to that directed by the 0.582Dl3-8bp-Zld1 construct (Fig. 3H ). These results suggest that a fixed arrangement of the Dl-and linked Zld-binding sites is required for lacZ expression in the neurogenic ectoderm, where there are low levels of Dl. There were no changes in the ventral limit of lacZ expression for any of the mutant enhancers tested, implying that the mutational changes did not interfere with shortrange repression mediated by Sna in the presumptive mesoderm.
Close proximity between Dl-and Bcd-binding sites in the minimal enhancer is required for broad lacZ expression A total of four Bcd-binding sites were found in the full-length sog shadow enhancer, three of which are shared with the 0.582 kb minimal enhancer (Figs. 2C, D and Table S5 ). However, the 0.686-and 0.582 kb constructs generated similar patterns of lacZ expression (Figs. 4A and B) , suggesting that the three Bcd-binding sites in the minimal enhancer are sufficient to mediate the typical pattern of sog expression, even if Bcd is involved in enhancer activity. Two (B2 and B3) of the three Bcd-binding sites in the minimal enhancer are located adjacent to two Dl-binding sites (D1 and D2), while the remaining site (B4) is located beside a nearby Zld-binding site (Z1). We first tested if Bcd is necessary for sog expression in the neurogenic ectoderm. To do this, we altered the core consensus sequences of the three Bcd-binding sites by sitedirected mutagenesis. Mutations in the three Bcd sites resulted in catastrophic reduction in lacZ expression (Fig. 4C) . Lack of either B2 (Fig. 4D) or B3 (Fig. 4E ) gradually diminished lacZ expression in the anterior half of the embryos, whereas mutation of the forth Bcd site (B4) did not appear to be deleterious to lacZ expression (Fig. 4F) . These results suggest that the two Bcd-binding sites (B2 and B3) linked to the two Dl-binding sites (D1 and D2) are required for normal lacZ expression.
To test for a possible synergistic interaction between the Dl-and linked Bcd-binding sites, the helical phasing between the Dl-and Bcd-binding sites was changed by inserting spacer sequences between them. A 7-bp spacer sequence was inserted between D1 and B2 sites (Table S1 ) to interfere with helical phasing between Dl and Bcd proteins on the DNA. The elongated distance between the sites resulted in a significant and gradual decrease in lacZ expression in the anterior half of the embryo (Fig. 4G) . The 0.582 Dl2-7bp-Bcd3 construct produced a similar lacZ expression pattern to that directed by the 0.582 Dl1-7bp-Bcd2 construct (Fig.  4H) . These results suggest that like the transcriptional synergy between Dl and Zld, there is also synergistic interaction between Dl-and Bcd-binding sites, and that this is required for normal sog expression in the neurogenic ectoderm.
Bcd-binding sites are also required for lacZ expression directed by the sog primary enhancer
It is believed that sog expression in the neurogenic ectoderm of the cellularizing blastoderm is directed by the collaboration (Fig. 1) (Table S8 ) (Markstein et al., 2002; Hong et al., 2008a) . Critical involvement of Bcd in sog shadow enhancer activity (Fig. 4) raised the question of whether the primary enhancer also requires Bcd for its transcriptional activity. To evaluate this, core sequences of the Bcd binding consensus sequence in the primary enhancer were changed by site-directed mutagenesis ( Fig. 5 and Table S1 ). ClusterDraw analyses also identified a cluster of Dl-, Zld-, Sna-, and Bcd-binding sites that precisely corresponded to the previously found primary enhancer in the first intron within the sog transcription unit (Figs. 2A, B , Tables  S6 and S7 ). The primary enhancer contains three Bcd-binding sites, at least two of which are closely linked to Dl-binding sites (Fig.  5A) . Initially, the primary enhancer was found by a computational algorithm designed to search the Drosophila genome for clusters of three or four optimal Dl-binding sites (Markstein et al., 2002) . The ~400-bp primary enhancer directed lateral broad stripes of lacZ expression (Fig. 5B) , recapitulating the pattern of expression of sog (Fig. 1, top panel) . Consistent with the previous mutagenesis study of Bcd-binding sites in the shadow enhancer (Fig. 4) , loss of all Bcd-binding sites resulted in a narrow lacZ expression pattern (Fig. 5C ). In particular, the mutant version of the primary enhancer almost failed to activate lacZ in the anterior half of the transgenic embryo. The dependence of both enhancers on Bcd activity strongly implies that the broad sog lateral stripes in the neurogenic ectoderm require transcriptional synergy between Dl and Bcd in addition to transcriptional synergy between Dl and Zld.
Discussion
The current study presents evidence that transcriptional synergy between Dl and Zld and between Dl and Bcd is required for the broad pattern of sog expression observed in the neurogenic ectoderm of cellularizing blastoderm. It has been proposed that linked heterotypic activator sites can amplify transcriptional signals in an analogous manner to bipolar transistors in electronic circuits (Papatsenko and Levine, 2007) . One activator in the pair functions as the signal carrier to produce a very specific expression profile. The other activator, expressed at higher levels, exhibits a broad or ubiquitous distribution. Synergistic interaction between the signal carrier and the broad or ubiquitous activator converts the weak specific signal to a functional transcription outcome via signal amplification. Dl and Zld very likely function as the signal carrier and broad amplifier, respectively. The ubiquitous maternal Zld amplifies diminishing concentrations of nuclear Dl in lateral and dorsal parts of the neurogenic ectoderm to delineate the broad profile of sog expression. The experimentally demonstrated transcriptional synergy between Dl and Zld in the sog shadow minimal enhancer (Fig.  3) indicates that signal amplification mediated by the heterotypic site combination is one of the mechanisms that delimits broad sog expression in the neurogenic ectoderm.
The transcriptional synergy between Dl-and Bcd-binding sites, another example of signal amplification mediated by the linked heterotypic site combination (Papatsenko et al., 2009) , appears to play a critical role in typical sog expression. dl and bcd are representative maternal effect genes that initiate AP and DV patterning of the early embryo, respectively (Berleth et al., 1988; Reeves and Stathopoulos, 2009) . Although classic genetic studies suggested that pattern formation is independently regulated by two distinct sets of maternal effect genes expressed along AP and DV axes (St Johnston and Nüsslein-Volhard, 1992) , it is believed that AP gene expression can be modulated by DV genes and vice versa during early embryogenesis (Li et al., 2008) . However, the mechanism by which AP and DV genes cooperate to direct gene expression has remained obscure. Here, we present the first evidence that synergistic interactions between AP and DV genes delimit the expression profile of a patterning gene in the cellularizing blastoderm. Loss of Bcd-binding sites in the sog shadow minimal enhancer resulted in two characteristic lacZ expression patterns. First, there was a gradual loss of lacZ expression, at least in the anterior half of the early embryo (for instance Fig. 4D and E) , when enhancers were defective in a Bcd-binding site. The aberrant lacZ expression pattern is likely spatially complementary to the Bcd nuclear gradient with peak levels at the anterior pole and progressively diminishing levels in posterior regions (Porcher and Dostatni, 2010) , implying that the characteristic lacZ pattern is due to absence of binding of Bcd to its dedicated binding sites. The finding that a mutation in either the D1 Dl-or B2 Bcd-binding site in the minimal enhancer resulted in similar patterns of lacZ expression ( Fig. S3 and 4D ) also indicates that Dl and Bcd cooperatively occupy their linked Fig. 2A,B Fig. 4C with B) when driven by enhancers defective in Bcd-binding sites. The mutant version of the primary enhancer containing no Bcd-binding site showed the most dramatic reduction in lacZ expression width (Fig. 5C) . Why did the lack of Bcd-binding sites in both sog enhancers cause a catastrophic reduction in lacZ expression width despite intact linkages between the Dl-and Zld-binding sites? It is plausible that the ability of the enhancer to interpret positional information for establishing DV pattern formation was hampered by removal of Bcd-binding sites. Perhaps cells also respond to AP positional information when initiating early patterning gene expression along the DV axis under the control of an unknown principle. In fact, dorsal-type spacing of a segmentation gene fushi tarazu (ftz) occurs all sides of the embryos lacking any of 10 maternal-effect DV polarity genes (Carroll et al., 1987) . These results suggest the existence of more sophisticated contacts between the AP and DV positional information.
The minimal enhancer identified here contains two pairs of Dl-and linked Zld-binding sites; Dl3-Zld1 and Dl5-Zld3 (Fig. 2C) . Centers of the Dl3 and Dl5 sites are located 12 and 21 bp away from those of the Zld1 and Zld3 sites, respectively (Tables S2, S3 , S5, and S8). Inserting an 8-bp "spacer" sequence between Dl3 and Zld1 sites separated them by 20 bp, which is almost identical to the distance between Dl5 and Zld3 sites (Fig. 3G) . Alteration in spacing of Dl3 and Zld1 sites caused narrow lacZ expression (Fig. 3G ) similar to that directed by enhancers containing a mutant Zld-binding site (Figs. 3D and F) , implying that the phasing mutant pair of Dl3-Zld1 sites separated by the 20-bp spacer did not function normally, whereas the Dl5 and Zld3 sites separated by 21-bp spacer worked properly. The same was true for the Dl1 and Bcd2 site pair interrupted by a 7-bp extra spacer (Fig. 4G) . How can two pairs of binding sites separated by comparable spacers show differential transcriptional competency? The simplest interpretation is that the overall structure of a protein complex built on the minimal enhancer is more important than the strict spacing requirement among the transcription factors for synergistic transcriptional activation. Proper binding of Dl and Zld (or Bcd) to their linked sites constitutes a critical platform to build a higher order cofactor complex for communicating with the RNA polymerase complex. Perhaps lack of a factor in the complex disrupts the structural topology of the platform, thereby leading to failure to assemble a complete cofactor complex. Functional impairment mediated by an alteration in phasing is evocative of the mammalian enhanceosome, which controls the expression of the b-interferon gene (b-IFN) (Thanos and Maniatis, 1995) . The enhanceosome includes a series of closely linked binding sites for several transcriptional activators including NFκB. Changes in the spacing of these binding sites lead to a severe disruption in structure and function (Panne et al., 2007) . However, it is hard to believe that every single nucleotide in the enhancer is sensitive to subtle changes. Rather, stabilizing selection pressure likely continually optimizes the overall arrangement of the cis-regulatory elements to discriminate unchangeable sequences from the flexible over evolutionary time (Ludwig et al., 2000) . It is conceivable that the two pairs of Dl-and Bcd-binding sites and the two sets of composite elements comprising Dl-, Zld-, and Sna-binding sites might be examples of invariant elements of the sog shadow minimal enhancer.
Materials and Methods
Plasmid construction, mutagenesis, and P element-mediated germline transformation Genomic DNA was isolated from yw 67c23 embryos aged 2-4 hours after egg deposition (AED) using previously described methods. All genomic regions used for P element-mediated germline transformation were prepared by polymerase chain reaction (PCR) amplification (Table S1 in Supplementary Material) of genomic DNA. PCR-amplified genomic fragments were cloned into the Promega™ pGEM ® -T Easy vector, and sequences of the cloned fragments were verified by DNA sequencing. Cloned fragments were digested with NotI and inserted into a modified version of the [(-42)-eveP-lacZ]-pCaSpeR vector , in which the EcoRI site upstream of the even-skipped (eve) promoter (eveP) is replaced with a NotI site. All enhancer sequences were oriented in a 5' to 3' direction relative to the sog transcription start site. Site-directed mutagenesis was performed with a Stratagene™ QuikChange ® Multi Site-Directed Mutagenesis Kit and oligonucleotide primers for introducing site-specific mutations (Table S1 ). Transformation constructs were introduced into the germline of Drosophila melanogaster as described previously (Rubin and Spradling, 1982) . At least five independent lines were generated and tested for each construct.
Bioinformatics
PFMs of Dl-, Zld-, Sna-, and Bcd-binding sites were obtained from in vitro (Fig. S1 in Supplementary Material) (Papatsenko, 2007) and in vivo (Fig. S2) (Zhu et al., 2011) DNA binding assays. The in vitro data were generated by DNase footprinting analyses and systematic evolution of ligands by exponential enrichment (SELEX) experiments performed with recombinant Dl, Sna, and Bcd proteins (http://line.bioinfolab.net/webgate/ help.htm#mtfform). The in vitro data for Zld-binding sequences were produced by chromatin-immunoprecipitation followed by genomic DNA tiling array (ChIP-chip) analysis (Nien et al., 2011) , because DNase footprinting and SELEX data for Zld-binding sites were not available at the time of this study. The in vivo data were derived from the FlyFactorSurvey database, which is a library of the binding site preferences of transcription factors in D. melanogaster generated by the high-throughput bacterial one-hybrid (B1H) system (http://pgfe.umassmed.edu/ffs/). The ClusterDraw algorithm was given ~62 kb of the genomic sequence of the sog locus (X:15,588,413-15,650,156) and either in vitro or in vivo PFMs of Dl, Zld, Sna, and Bcd. The D. melanogaster genomic sequence was obtained from the Flybase GBrowse database (http://flybase.org/cgi-bin/gbrowse2/dmel/, BDGP genome assembly 5 and D. melanogaster annotation 5.56). ClusterDraw analysis with either in vitro or in vivo PFMs indicated the presence of Dl-, Zld-, Sna-, and Bcd-binding sites (Table S2 -S7) in sog primary and shadow enhancers (Table S8) in the ~62 kb genomic region. See Supplementary Material for more details regarding determination of putative functional Dl-, Zld-, Sna-, and Bcd-binding motifs in sog primary and shadow enhancers.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described in a previous study (Hong et al., 2013) . Briefly, embryos were collected 2-4 hours AED, dechorinated, fixed, and then hybridized with digoxigenin (DIG) UTP-labeled antisense lacZ RNA probes. The antisense lacZ RNA probe was produced by in vitro transcription with PCR-generated DNA templates.
